Cart
sales@molnova.com
CHAPS
CAS No. 75621-03-3
CHAPS( —— )
Catalog No. M24762 CAS No. 75621-03-3
CHAPS is a zwitterionic nondenaturing detergent for solubilizing membrane proteins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCHAPS
-
NoteResearch use only, not for human use.
-
Brief DescriptionCHAPS is a zwitterionic nondenaturing detergent for solubilizing membrane proteins.
-
DescriptionCHAPS is a zwitterionic nondenaturing detergent for solubilizing membrane proteins.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75621-03-3
-
Formula Weight614.88
-
Molecular FormulaC32H58N2O7S
-
Purity>98% (HPLC)
-
SolubilityH2O:46 mg/mL (74.81 mM)
-
SMILESO[C@@H]1CC[C@]2(C)[C@@]3([H])C[C@H](O)[C@]4(C)[C@@H]([C@H](C)CCC(NCCC[N+](C)(C)CCCS([O-])(=O)=O)=O)CC[C@@]4([H])[C@]3([H])[C@H](O)C[C@@]([H])2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ofri D, Ritter AM, Liu YF et al. Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding. J Neurochem. 1992 Feb;58(2):628-35.
molnova catalog
related products
-
Lys(Me)3-OH Chloride
NεNεNε-Trimethyl-L-lysine is a methylated derivative of the amino acid lysine. It is a component of histone proteins a precursor of carnitine and a coenzyme of fatty acid oxidation. NεNεNε--Trimethyl-L-lysine residues are found in a number of proteins and are generated by the action of S-adenosyl-L-methionine on exposed lysine residues.
-
WAY-639228
WAY-639228-A has potential antithrombotic and anticoagulant activity for the study of cerebral thrombosis.
-
dCeMM1
dCeMM1, a RBM39 glue degrader, re-directs the activity of the CRL4DCAF15 ligase and decreases RBM39 expression levels in WT KBM7 cells.
